Nonterah, Engelbert A.
Chatio, Samuel T.
Willis, Andy
Alale, Joseph A.
Zakariah-Akoto, Sawudatu
Darko, Natalie
Curtis, Ffion
Kunutsor, Setor K.
Jones, Ceri
Seidu, Samuel
Ansah, Patrick O.
Funding for this research was provided by:
European Foundation for the Study of Diabetes and Lilly through the ‘Exploring and applying new strategies in diabetes (EXPAND) programme
Article History
Received: 8 July 2024
Accepted: 8 October 2024
First Online: 24 October 2024
Declarations
:
: The study received ethical approval from the Navrongo Health Research Centre Institutional Review Board (ref: NHRCIRB47I). Consent was sort from the leadership of the various FBC for the medical screening, additional written informed consent was obtained from every individual prior to the screening where possible, with fingerprint consent taken from participants who could not sign. All research procedures were conducted according to ethical principles as outlined in the guidelines and regulations such as the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.